All the news Showing 10 of 565 articles from: United StatesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Kidney disease & HCV Higher kidney disease risk persists in people cured of hepatitis C Keith Alcorn / 19 July 2022 People with hepatitis C remain at higher risk of chronic kidney disease after clearing or being cured of hepatitis C and people with genotype 1 infection have a higher risk of kidney ... Starting treatment Why do people with HIV delay hepatitis C treatment? Keith Alcorn / 15 July 2022 Greater efforts by healthcare providers to build trusting relationships with people with HIV and hepatitis C, together with a greater focus on overcoming concerns about treatment side effects, are likely to be needed ... Treatment in liver transplanted Short-course treatment prevents hepatitis C after organ transplant Keith Alcorn / 24 June 2022 A seven-day course of direct-acting antiviral treatment started hours before an organ transplant prevented hepatitis C infection in everyone who received a transplant from a donor with hepatitis C, researchers from the Mayo ... CDC investigating 109 unusual hepatitis cases in kids in outbreak STAT / 09 May 2022 Eligibility for treatment 1.2 million initiated DAA treatment for HCV between 2014 and 2020 Healio / 13 April 2022 Treatment for people who use drugs Hepatitis C widespread but rarely treated in postpartum Medicaid beneficiaries with opioid use disorder University of Pittsburgh / 13 April 2022 Treatment for people who use drugs Accessible care achieves higher hepatitis C cure rate in people who inject drugs Keith Alcorn / 28 March 2022 Hepatitis C care located within a needle and syringe programme in New York achieved a three times higher cure rate than referral to a patient navigator and linkage to medical care at ... Coronavirus COVID-19 pandemic led to a 30% drop in new hepatitis C treatments in the United States Keith Alcorn / 22 March 2022 Hepatitis C testing and treatment initiations in the United States dropped by 30% at the beginning of the COVID-19 pandemic in 2020 and treatment initiations did not recover to previous levels during ... Screening and testing policy No-click system doubles hepatitis c screening orders, study finds University of Pennsylvania School of Medicine / 21 March 2022 Confidentiality, consent and medical ethics Dangerous Medicine: The Story Behind Human Experiments with Hepatitis – review The Guardian / 09 March 2022 ← First12345...57Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive